Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Iida

Showing results (631-640 of 640) with videos related to

Pageof 64
Sort By:
You have reached the last page of results.This site can display upto 640 results.
Leukemia|March 17, 2000
MUM1/IRF4 expression as a frequent event in mature lymphoid malignanciesK Tsuboi, S Iida, H Inagaki, et al.
Blood|August 26, 1998
Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myelomaP H Rao, J C Cigudosa, Y Ning, et al.
Endoscopy|May 30, 2013
Scurvy with gastrointestinal bleedingA Ohta, S Yoshida, H Imaeda, et al.
Immunity|April 6, 2001
IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancyG Hatzivassiliou, I Miller, J Takizawa, et al.
Japanese Journal of Cancer Research : Gann|June 29, 2001
Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocationsI Hanamura, S Iida, Y Akano, et al.
Blood Cancer Journal|August 2, 2012
Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicingM Ri, E Tashiro, D Oikawa, et al.
Nihon Sanka Fujinka Gakkai Zasshi|November 1, 1981
[Studies of solid ovarian tumors in Tokai District (author's transl)]Y Tomoda, M Ohta, H Ushijuma, et al.
Leukemia|November 9, 2012
Mutations of the epigenetics-modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemiaS Wakita, H Yamaguchi, I Omori, et al.
Sei Roka Kango Daigaku Kiyo|January 1, 1996
[The new curriculum at St. Luke's College of Nursing (1995 edition)]M Hishinuma, M Koyama, M Kojima, et al.
Blood Cancer Journal|February 28, 2015
t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugsT Narita, A Inagaki, T Kobayashi, et al.
Pageof 64

Showing results (631-640 of 640) with videos related to

Sort By:
Pageof 64
You have reached the last page of results.This site can display upto 640 results.
Leukemia|March 17, 2000
MUM1/IRF4 expression as a frequent event in mature lymphoid malignanciesK Tsuboi, S Iida, H Inagaki, et al.
Blood|August 26, 1998
Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myelomaP H Rao, J C Cigudosa, Y Ning, et al.
Endoscopy|May 30, 2013
Scurvy with gastrointestinal bleedingA Ohta, S Yoshida, H Imaeda, et al.
Immunity|April 6, 2001
IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancyG Hatzivassiliou, I Miller, J Takizawa, et al.
Japanese Journal of Cancer Research : Gann|June 29, 2001
Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocationsI Hanamura, S Iida, Y Akano, et al.
Blood Cancer Journal|August 2, 2012
Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicingM Ri, E Tashiro, D Oikawa, et al.
Nihon Sanka Fujinka Gakkai Zasshi|November 1, 1981
[Studies of solid ovarian tumors in Tokai District (author's transl)]Y Tomoda, M Ohta, H Ushijuma, et al.
Leukemia|November 9, 2012
Mutations of the epigenetics-modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemiaS Wakita, H Yamaguchi, I Omori, et al.
Sei Roka Kango Daigaku Kiyo|January 1, 1996
[The new curriculum at St. Luke's College of Nursing (1995 edition)]M Hishinuma, M Koyama, M Kojima, et al.
Blood Cancer Journal|February 28, 2015
t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugsT Narita, A Inagaki, T Kobayashi, et al.
Pageof 64